On its face, Daubert v. Merrell Dow Pharmaceuticals was about as easy a case as the Supreme Court gets. The plaintiff claimed that their birth defect were caused by the anti-nausea drug Bendectin, which their mothers had used during their gestation. In response to a motion for summary judgment by the defendant, the plaintiff presented affidavits of eight expert witnesses who offered their opinion - based on a variety of studies- that Bendectin was indeed the culprit. The federal district court that heard the motion granted summary judgment to the defendant, and the Ninth Circuit affirmed. Both lower court held that critical portions of the plaintiff \u27 evidence were inadmissible, and that without that evidence the plaintiffs had not met t...
In Frye v. United States, the Court of Appeals of the District of Columbia affirmed a trial court\u2...
In Daubert v. Merrell Dow Pharmaceuticals, Inc., the United States Supreme Court held that the Feder...
A recent report of the President’s Council of Advisors on Science and Technology questioned the vali...
On its face, Daubert v. Merrell Dow Pharmaceuticals was about as easy a case as the Supreme Court ge...
In the 1993 landmark case Daubert v. Merrell Dow Pharmaceuticals, the United States Supreme Court ar...
The thesis of this article is that the Supreme Court decision in Daubert v. Merrell Dow Pharmaceutic...
In the US Supreme Court's Daubert v Merrell Dow Pharmaceuticals, Inc decision, federal judges were d...
In Daubert v. Merrell Dow Pharmaceuticals, the United States Supreme Court replaced the general acce...
The controversy over the proper standard for the admissibility of scientific evidence is an argument...
In reaching its recent decision in Daubert v. Merrell Dow Pharmaceuticals, Inc., the United States S...
In Daubert v. Merrell Dow Pharmaceuticals Inc., the Supreme Court sensibly held that testimony purpo...
Twenty-five years ago, the Supreme Court decided one of the most important cases concerning the use ...
In its famous opinion in Daubert v. Merrell Dow Pharmaceuticals, the U.S. Supreme Court took a major...
In 1993, the Supreme Court of the United States stated that with the federal adoption of statutory r...
In one of the most anticlimactic cases in recent years, the Supreme Court ruled on the last day of i...
In Frye v. United States, the Court of Appeals of the District of Columbia affirmed a trial court\u2...
In Daubert v. Merrell Dow Pharmaceuticals, Inc., the United States Supreme Court held that the Feder...
A recent report of the President’s Council of Advisors on Science and Technology questioned the vali...
On its face, Daubert v. Merrell Dow Pharmaceuticals was about as easy a case as the Supreme Court ge...
In the 1993 landmark case Daubert v. Merrell Dow Pharmaceuticals, the United States Supreme Court ar...
The thesis of this article is that the Supreme Court decision in Daubert v. Merrell Dow Pharmaceutic...
In the US Supreme Court's Daubert v Merrell Dow Pharmaceuticals, Inc decision, federal judges were d...
In Daubert v. Merrell Dow Pharmaceuticals, the United States Supreme Court replaced the general acce...
The controversy over the proper standard for the admissibility of scientific evidence is an argument...
In reaching its recent decision in Daubert v. Merrell Dow Pharmaceuticals, Inc., the United States S...
In Daubert v. Merrell Dow Pharmaceuticals Inc., the Supreme Court sensibly held that testimony purpo...
Twenty-five years ago, the Supreme Court decided one of the most important cases concerning the use ...
In its famous opinion in Daubert v. Merrell Dow Pharmaceuticals, the U.S. Supreme Court took a major...
In 1993, the Supreme Court of the United States stated that with the federal adoption of statutory r...
In one of the most anticlimactic cases in recent years, the Supreme Court ruled on the last day of i...
In Frye v. United States, the Court of Appeals of the District of Columbia affirmed a trial court\u2...
In Daubert v. Merrell Dow Pharmaceuticals, Inc., the United States Supreme Court held that the Feder...
A recent report of the President’s Council of Advisors on Science and Technology questioned the vali...